| Year |
Citation |
Score |
| 2023 |
Jespersen F, Petersen SL, Andersen P, Sellebjerg F, Magyari M, Sørensen PS, Blinkenberg M. Autologous hematopoietic stem cell transplantation of patients with aggressive relapsing-remitting multiple sclerosis: Danish nation-wide experience. Multiple Sclerosis and Related Disorders. 76: 104829. PMID 37364374 DOI: 10.1016/j.msard.2023.104829 |
0.328 |
|
| 2023 |
Wegener A, Andersen NS, Friis LS, Petersen SL, Schjødt I, Kornblit B, Sengeløv H, Gjærde LK. Triple-drug GVHD prophylaxis after HLA-matched unrelated donor non-myeloablative allogenic hematopoietic stem cell transplantation. Transplantation and Cellular Therapy. PMID 37301257 DOI: 10.1016/j.jtct.2023.05.022 |
0.501 |
|
| 2022 |
Gjærde LK, Ostrowski SR, Schierbeck F, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H. Pre-Transplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Non-Relapse Mortality in Allogeneic Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. PMID 36375798 DOI: 10.1016/j.jtct.2022.11.009 |
0.483 |
|
| 2022 |
Gjaerde LK, Jakobsen LH, Juhl-Christensen C, Olesen G, Petruskevicius I, Severinsen MT, Marcher CW, Theilgaard-Mönch K, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H. Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: A Danish population-based cohort study. British Journal of Haematology. PMID 36263998 DOI: 10.1111/bjh.18511 |
0.464 |
|
| 2022 |
Schierbeck F, Mortensen J, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H. Pulmonary Function is a Strong Predictor of 2-year Overall Survival and Non-relapse Mortality after Allogenic Hematopoietic Cell Transplantation. European Journal of Haematology. PMID 36153797 DOI: 10.1111/ejh.13869 |
0.478 |
|
| 2022 |
Gjærde LK, Ostrowski SR, Jørgensen NR, Schierbeck F, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H. Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation. Transplant Immunology. 74: 101650. PMID 35718288 DOI: 10.1016/j.trim.2022.101650 |
0.484 |
|
| 2021 |
Sengeløv H, Petersen SL. [Bone marrow transplantation and chimeric antigen receptot T cellular therapy]. Ugeskrift For Laeger. 183. PMID 34709159 |
0.374 |
|
| 2021 |
Gjærde LK, Ostrowski SR, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H. Pre-transplantation plasma vitamin D levels and acute graft-versus-host disease after myeloablative hematopoietic cell transplantation in adults. Transplant Immunology. 68: 101437. PMID 34273495 DOI: 10.1016/j.trim.2021.101437 |
0.448 |
|
| 2021 |
Nabergoj M, Mauff K, Robin M, Kröger N, Angelucci E, Poiré X, Passweg J, Radujkovic A, Platzbecker U, Robinson S, Rambaldi A, Petersen SL, Stölzel F, Stelljes M, Ciceri F, et al. Outcomes following second allogeneic haematopoietic cell transplantation in patients with myelofibrosis: a retrospective study of the Chronic Malignancies Working Party of EBMT. Bone Marrow Transplantation. PMID 33824436 DOI: 10.1038/s41409-021-01271-4 |
0.497 |
|
| 2021 |
Gjaerde LK, Brooks PT, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Dam Nielsen S, Ostrowski SR, Sengeløv H. Functional immune reconstitution early after allogeneic hematopoietic cell transplantation: A comparison of pre- and post-transplantation cytokine responses in stimulated whole-blood. Scandinavian Journal of Immunology. e13042. PMID 33772836 DOI: 10.1111/sji.13042 |
0.302 |
|
| 2020 |
Gjaerde LK, Ostrowski SR, Minculescu L, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H. Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantation. European Journal of Haematology. PMID 33314420 DOI: 10.1111/ejh.13567 |
0.339 |
|
| 2020 |
Minculescu L, Fischer-Nielsen A, Haastrup E, Ryder LP, Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL, Sengelov H, Marquart HV. Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation. Frontiers in Immunology. 11: 1068. PMID 32547559 DOI: 10.3389/Fimmu.2020.01068 |
0.576 |
|
| 2020 |
Cooper JP, Storer BE, Granot N, Gyurkocza B, Sorror ML, Chauncey TR, Shizuru J, Franke GN, Maris MB, Boyer M, Bruno B, Sahebi F, Langston AA, Hari P, Agura ED, ... Petersen SL, et al. Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades. Haematologica. PMID 32499241 DOI: 10.3324/Haematol.2020.248187 |
0.587 |
|
| 2020 |
Wedge E, Sengeløv H, Hansen JW, Andersen NS, Schjoedt I, Petersen SL, Kornblit B, Grønbæk K, Friis LS. Improved outcomes after allogenic hematopoietic stem cell transplantation with Fludarabine/Treosulfan for patients with myelodysplastic syndromes. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32088368 DOI: 10.1016/J.Bbmt.2020.02.010 |
0.49 |
|
| 2020 |
Jespersen F, Fischer-Nielsen A, Petersen SL, Blinkenberg M. [Autologous haematopoietic stem cell transplantation of patients with multiple sclerosis]. Ugeskrift For Laeger. 181. PMID 31538572 |
0.429 |
|
| 2019 |
Gjærde LK, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Ostrowski SR, Sengeløv H. Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. PMID 31772337 DOI: 10.1038/S41409-019-0760-5 |
0.513 |
|
| 2019 |
Minculescu L, Marquart HV, Ryder LP, Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL, Haastrup E, Fischer-Nielsen A, Reekie J, Sengelov H. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation. Frontiers in Immunology. 10: 1997. PMID 31507601 DOI: 10.3389/Fimmu.2019.01997 |
0.555 |
|
| 2019 |
Helby J, Petersen SL, Kornblit B, Nordestgaard BG, Mortensen BK, Bojesen SE, Sengeløv H. Mononuclear Cell Telomere Attrition Is Associated with Overall Survival after Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 25: 496-504. PMID 30266676 DOI: 10.1016/J.Bbmt.2018.09.025 |
0.578 |
|
| 2018 |
Andersen TT, Hansen ML, Petersen SL, Ewertsen C. Carotidynia in a Patient Receiving an Allogeneic Hematopoietic Cell Transplantation: A Case Report to Support a Disputed Entity. Ultrasound International Open. 4: E106-E108. PMID 30345417 DOI: 10.1055/a-0647-2330 |
0.483 |
|
| 2018 |
Wareham NE, Da Cunha-Bang C, Borges ÁH, Ekenberg C, Gerstoft J, Gustafsson F, Hansen D, Heilmann C, Helleberg M, Hillingsø J, Krohn PS, Lodding IP, Lund TK, Lundgren L, Mocroft A, ... ... Petersen SL, et al. Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial results. Medicine. 97: e11564. PMID 30024557 DOI: 10.1097/Md.0000000000011564 |
0.411 |
|
| 2018 |
Nygaard M, Karlsmark T, Andersen NS, Schjødt IM, Petersen SL, Friis LS, Kornblit BT, Sengeløv H. Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease-experience with three different approaches. Bone Marrow Transplantation. PMID 29907805 DOI: 10.1038/S41409-018-0262-X |
0.389 |
|
| 2018 |
Nygaard M, Karlsmark T, Andersen NS, Schjødt IM, Petersen SL, Friis LS, Kornblit BT, Sengeløv H. Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease. Bone Marrow Transplantation. PMID 29740177 DOI: 10.1038/S41409-018-0206-5 |
0.414 |
|
| 2018 |
Minculescu L, Marquart HV, Ryder LP, Schjødt I, Friis LS, Kornblit BT, Petersen SL, Andersen NS, Hastrup EK, Fischer-Nielsen A, Sengeloev H. Improved Relapse-Free Survival and Overall Survival in Patients with High Immune Reconstitution of Gamma Delta T Cells 2 Months after Allogeneic Hematopoietic Stem Cell Transplantation Blood. 132: 3396-3396. DOI: 10.1182/Blood-2018-99-111777 |
0.585 |
|
| 2018 |
Andersen NS, Kornblit B, Petersen S, Friis LS, Schioedt I, Sengeloev H. In Selected Older Patients (Pts) Non-Myeloablative (NMA) Based Allogeneic Haematopoietic Cell Transplantation (alloHCT) Reach Acceptable Morbidity and Survival. a Danish Retrospective Single Center Study Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.385 |
0.53 |
|
| 2018 |
Nygaard M, Karlsmark T, Smedegaard N, Schjødt I, Friis LS, Petersen S, Kornblit B, Sengeløv H. Experience with the Use of Infliximab and/or Extracorporeal Photopheresis in Steroid-Refractory Acute Graft Versus Host Disease Biology of Blood and Marrow Transplantation. 24. DOI: 10.1016/J.Bbmt.2017.12.153 |
0.404 |
|
| 2017 |
Wareham NE, Cunha-Bang CD, Borges ÁH, Ekenberg C, Gerstoft J, Gustafsson F, Hansen D, Helleberg M, Heilmann C, Hillingsø J, Krohn PS, Lodding IP, Lund TK, Lundgren L, Mocroft A, ... ... Petersen SL, et al. Classification of Death Causes after Transplantation (CLASS): Evaluation of Methodology and Initial Results Open Forum Infectious Diseases. 4. DOI: 10.1093/Ofid/Ofx163.1886 |
0.429 |
|
| 2016 |
Sandmaier BM, Maloney DG, Storer BE, Olesen G, Maris MB, Gutman JA, Petersen SL, Langston A, Chauncey T, Bethge W, Pulsipher MA, Kornblit BT, Woolfrey AE, Mielcarek M, Martin PJ, et al. Sirolimus Combined with Mycophenolate Mofetil (MMF) and Cyclosporine (CSP) Significantly Improves Prevention of Acute Graft-Versus-Host-Disease (GVHD) after Unrelated Hematopoietic Cell Transplantation (HCT): Results from a Phase III Randomized Multi-Center Trial Blood. 128: 506-506. DOI: 10.1182/Blood.V128.22.506.506 |
0.45 |
|
| 2013 |
Sengeløv H, Gerds TA, Brændstrup P, Kornblit B, Mortensen BK, Petersen SL, Vindeløv LL. Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning. Bone Marrow Transplantation. 48: 1185-1191. PMID 23524638 DOI: 10.1038/Bmt.2013.38 |
0.427 |
|
| 2013 |
Sengelov H, Gerds T, Braendstrup P, Kornblit B, Mortensen BK, Petersen S, Vindeloev L. Long-Term Survival After Allogeneic Haematopoietic Cell Transplantation for Acute Myeloid Leukemia. Comparable Results From Myeloablative and Non-Myeloablative Conditioning in Young and Elderly Patients Biology of Blood and Marrow Transplantation. 19. DOI: 10.1016/J.Bbmt.2012.11.449 |
0.542 |
|
| 2012 |
Mortensen BK, Petersen SL, Kornblit B, Andersen PK, Braendstrup P, Andersen NS, Sengeløv H, Vindeløv L. Single-institution long-term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma. European Journal of Haematology. 89: 151-9. PMID 22574687 DOI: 10.1111/J.1600-0609.2012.01801.X |
0.463 |
|
| 2010 |
Kornblit B, Masmas T, Petersen SL, Madsen HO, Heilmann C, Schejbel L, Sengeløv H, Müller K, Garred P, Vindeløv L. Association of HMGB1 Polymorphisms with Outcome after Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation. 16: 239-252. PMID 19819342 DOI: 10.1016/J.Bbmt.2009.10.002 |
0.507 |
|
| 2009 |
Kornblit B, Masmas TN, Petersen SL, Madsen HO, Heilmann C, Schejbel L, Sengeloev H, Müller K, Garred P, Vindelov L. Association of HMGB1 Polymorphisms with Outcome After Allogeneic Hematopoietic Cell Transplantation. Blood. 114: 2260-2260. DOI: 10.1182/Blood.V114.22.2260.2260 |
0.492 |
|
| 2008 |
Kollgaard T, Hadrup SR, Petersen SL, Masmas TN, Andersen MH, Spierings E, Vindeløv L, Straten PT. Natural T-cell responses against minor histocompatibility antigen (mHag) HY following HLA-matched hematopoietic cell transplantation: what are the requirements for a 'good' mHag? Leukemia. 22: 1948-51. PMID 18401420 DOI: 10.1038/Leu.2008.75 |
0.568 |
|
| 2008 |
Masmas TN, Petersen SL, Madsen HO, Ryder LP, Kornblit B, Svejgaard A, Andersen P, Dickmeiss E, Vindeløv LL. Graft rejection after hematopoietic cell transplantation with nonmyeloablative conditioning. American Journal of Hematology. 83: 563-9. PMID 18383319 DOI: 10.1002/Ajh.21168 |
0.581 |
|
| 2008 |
Kornblit B, Masmas T, Madsen HO, Ryder LP, Svejgaard A, Jakobsen B, Sengeløv H, Olesen G, Heilmann C, Dickmeiss E, Petersen SL, Vindeløv L. Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants. Bone Marrow Transplantation. 41: 851-9. PMID 18246114 DOI: 10.1038/Bmt.2008.10 |
0.543 |
|
| 2008 |
Kornblit B, Masmas T, Madsen HO, Ryder LP, Svejgaard A, Jakobsen B, Sengeløv H, Olesen G, Heilmann C, Dickmeiss E, Petersen SL, Vindeløv L. 10 Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: Disease-specific outcome, complications and hospitalization requirements of the first 100 transplants Apmis. 116: 422-422. DOI: 10.1111/J.1600-0463.2008.00Abs1165_22.X |
0.54 |
|
| 2007 |
Petersen SL. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies: Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning Danish Medical Bulletin. 54: 112-139. PMID 17521527 |
0.595 |
|
| 2007 |
Kornblit B, Masmas T, Petersen SL, Madsen HO, Garred P, Vindelov L. The PTPN22 1858C/T Polymorphism Is Associated with the Development of Grade 3 to 4 Acute Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation Following Nonmyeloablative Conditioning. Blood. 110: 1969-1969. DOI: 10.1182/Blood.V110.11.1969.1969 |
0.544 |
|
| 2007 |
Masmas TN, Friis-Hansen L, Johansen JV, Petersen SL, Kornblit BT, Winther O, Nielsen FC, Vindelov L. The Predictive Value of Gene Expression Profiles for Acute Graft-Versus-Host Disease after Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning for Hematological Malignancy. Blood. 110: 1079-1079. DOI: 10.1182/Blood.V110.11.1079.1079 |
0.56 |
|
| 2006 |
Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Dickmeiss E, Vindeløv LL. Cytokine gene expression in peripheral blood mononuclear cells and alloreactivity in hematopoietic cell transplantation with nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 12: 48-60. PMID 16399568 DOI: 10.1016/J.Bbmt.2005.09.002 |
0.518 |
|
| 2006 |
Kollgaard T, Petersen SL, Hadrup SR, Masmas TN, Seremet T, Andersen MH, Madsen HO, Vindeløv L, thor Straten P. Evidence for involvement of clonally expanded CD8+ T cells in anticancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantation. Leukemia. 19: 2273-80. PMID 16304575 DOI: 10.1038/Sj.Leu.2403972 |
0.493 |
|
| 2005 |
Petersen SL, Sidorov IA, Russell CA, Dickmeiss E, Vindeløv LL. Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation. Transplantation. 80: 573-81. PMID 16177628 DOI: 10.1097/01.Tp.0000173390.31035.10 |
0.524 |
|
| 2005 |
Masmas TN, Madsen HO, Petersen SL, Ryder LP, Svejgaard A, Alizadeh M, Vindeløv LL. Evaluation and automation of hematopoietic chimerism analysis based on real-time quantitative polymerase chain reaction. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 11: 558-66. PMID 15983556 DOI: 10.1016/J.Bbmt.2005.04.004 |
0.43 |
|
| 2005 |
Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Dickmeiss E, Vindelov L. Cytokine Gene Expression in Peripheral Blood Mononuclear Cells Points to Interleukin-10 as an Inhibitor of Alloreactivity Following Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning. Blood. 106: 5342-5342. DOI: 10.1182/Blood.V106.11.5342.5342 |
0.514 |
|
| 2005 |
Masmas TN, Petersen SL, Madsen HO, Ryder L, Dickmeiss E, Svejgaard A, Vindelov L. Kinetics of Early Donor Chimerism after Nonmyeloablative Haematopoietic Stem Cell Transplantation Monitored with High-Resolution Real Time Quantitative PCR. Blood. 106: 3669-3669. DOI: 10.1182/Blood.V106.11.3669.3669 |
0.449 |
|
| 2005 |
Kollgaard T, Petersen SL, Hadrup SR, Masmas TN, Seremet T, Andersen MH, Madsen HO, Vindelov L, Straten PT. Evidence for Involvement of Clonally Expanded CD8+ T Cells in Anti-Cancer Immune Responses in CLL Patients Following Nonmyeloablative Conditioning and Hematopoietic Cell Transplantation (HCT). Blood. 106: 1260-1260. DOI: 10.1182/Blood.V106.11.1260.1260 |
0.487 |
|
| 2004 |
Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Masmas TN, Dickmeiss E, Heilmann C, Vindeløv LL. Chimerism studies in HLA-identical nonmyeloablative hematopoietic stem cell transplantation point to the donor CD8(+) T-cell count on day + 14 as a predictor of acute graft-versus-host disease. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 10: 337-46. PMID 15111933 DOI: 10.1016/J.Bbmt.2004.01.003 |
0.555 |
|
| 2004 |
Petersen SL, Madsen HO, Ryder LP, Svejgaard A, Jakobsen BK, Sengeløv H, Heilmann C, Dickmeiss E, Vindeløv LL. Haematopoietic stem cell transplantation with non-myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution. British Journal of Haematology. 125: 225-31. PMID 15059146 DOI: 10.1111/J.1365-2141.2004.04897.X |
0.577 |
|
| 2003 |
Petersen SL, Ryder LP, Björk P, Madsen HO, Heilmann C, Jacobsen N, Sengeløv H, Vindeløv LL. A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors. Bone Marrow Transplantation. 32: 65-72. PMID 12815480 DOI: 10.1038/Sj.Bmt.1704084 |
0.566 |
|
| 2001 |
Russell CA, Petersen SL, Heilmann C, Madsen HO, Vindeløv LL. Autoreactivity, backstimulation and reproducibility in a helper T lymphocyte precursor assay. Journal of Immunological Methods. 251: 109-121. PMID 11292487 DOI: 10.1016/S0022-1759(01)00311-8 |
0.515 |
|
| 1999 |
Petersen SL, Wagner A, Gimsing P. Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature. American Journal of Hematology. 62: 228-233. PMID 10589078 DOI: 10.1002/(Sici)1096-8652(199912)62:4<228::Aid-Ajh5>3.0.Co;2-3 |
0.445 |
|
| Show low-probability matches. |